In the next phase of the University’s electronic medical record (EMR) implementation to transform patient care, the University of Miami Miller School of Medicine and UHealth have launched the EMR system UChart at Sylvester Comprehensive Cancer Center/University of Miami Hospital and Clinics (UMHC).
Drawing on their clinical and scientific experience, researchers at the University of Miami Miller School of Medicine have identified a new strategy for attacking esophageal adenocarcinoma (EAC), one of the most deadly forms of cancer.
The Miller School of Medicine, recognizing the need to educate a new generation of physicians in the growing complexities of medical care, has introduced the Hospice and Palliative Medicine Fellowship Program.
University of Miami Miller School of Medicine faculty, residents and students participated in multiple sessions at the International Federation of Head and Neck Societies’ World Congress in New York.
Miller School of Medicine researchers have received three grants in the latest round of funding from the Florida Translational Research Program (FTRP), a state-funded initiative to advance drug discovery. All of the projects receiving awards focus on the discovery and development of novel small molecules for the treatment of disease, specifically cancer.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine is making a new state-of-the-art weapon available to its patients, becoming only the fourth facility in the U.S. and the first on the east coast to acquire an MRI-guided radiation therapy system from ViewRay Inc.
At 4:45 a.m., the sun isn’t up yet. Nonetheless, when Michael Montero, first-shift receptionist, and Miguel Figueroa, first-shift wellness instructor, arrive each weekday morning to open the recently renamed UHealth Fitness and Wellness Center, located on the 9th floor of the Clinical Research Building, the same group of guys is already waiting to get in and get started.
The National Institutes of Health/National Cancer Institute has awarded researchers at the Miller School of Medicine $3 million in funding over five years to explore breakthrough uses of MRI imaging and genetic signatures in managing prostate cancer diagnosis and treatment.
Theresa DiNardo Brown, Chief Communications Officer of the Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute, has been named Associate Vice President of Marketing and Communications for the Miller School of Medicine and UHealth, and Executive Director of Marketing and Communications for the Sylvester Comprehensive Cancer Center.
A collaborative Miller School study led by Priyamvada Rai, Ph.D., assistant professor of medicine in the Division of Gerontology and Geriatric Medicine, describes a novel therapeutic target in RAS-driven lung cancer, a common but untreatable carcinoma. The study, published in Oncogene, describes a critical role for MTH1, a protein which sanitizes oxidized DNA precursors, in facilitating tumor formation by activated KRAS.